PORTACCIO, EMILIO
 Distribuzione geografica
Continente #
NA - Nord America 12.769
EU - Europa 8.166
AS - Asia 5.752
SA - Sud America 794
Continente sconosciuto - Info sul continente non disponibili 221
AF - Africa 137
OC - Oceania 89
Totale 27.928
Nazione #
US - Stati Uniti d'America 12.559
RU - Federazione Russa 2.444
IT - Italia 2.017
SG - Singapore 1.612
CN - Cina 1.476
PL - Polonia 1.339
HK - Hong Kong 817
BR - Brasile 633
VN - Vietnam 571
SE - Svezia 531
IE - Irlanda 530
KR - Corea 514
FR - Francia 286
DE - Germania 266
FI - Finlandia 210
IN - India 181
UA - Ucraina 151
GB - Regno Unito 144
BD - Bangladesh 142
CA - Canada 121
TR - Turchia 94
AU - Australia 89
JP - Giappone 75
JO - Giordania 66
AR - Argentina 64
MX - Messico 47
ID - Indonesia 44
ES - Italia 42
NL - Olanda 42
CH - Svizzera 37
IQ - Iraq 35
ZA - Sudafrica 30
EC - Ecuador 28
CZ - Repubblica Ceca 23
CI - Costa d'Avorio 22
BE - Belgio 21
CO - Colombia 20
NG - Nigeria 20
IR - Iran 15
PK - Pakistan 15
VE - Venezuela 15
MA - Marocco 13
PH - Filippine 13
SC - Seychelles 12
UZ - Uzbekistan 11
AT - Austria 10
HN - Honduras 10
LT - Lituania 10
PE - Perù 10
PT - Portogallo 10
AE - Emirati Arabi Uniti 9
EG - Egitto 9
MK - Macedonia 9
RS - Serbia 8
TH - Thailandia 8
BO - Bolivia 7
PA - Panama 7
AZ - Azerbaigian 6
BJ - Benin 6
CL - Cile 6
JM - Giamaica 6
NP - Nepal 6
SA - Arabia Saudita 6
UY - Uruguay 6
BG - Bulgaria 5
CR - Costa Rica 5
DZ - Algeria 5
EU - Europa 5
KE - Kenya 5
MY - Malesia 5
PY - Paraguay 5
AL - Albania 4
HR - Croazia 4
HU - Ungheria 4
KZ - Kazakistan 4
PR - Porto Rico 4
AO - Angola 3
BH - Bahrain 3
CY - Cipro 3
GR - Grecia 3
IL - Israele 3
LU - Lussemburgo 3
SN - Senegal 3
TT - Trinidad e Tobago 3
BB - Barbados 2
DK - Danimarca 2
GE - Georgia 2
GT - Guatemala 2
LB - Libano 2
LK - Sri Lanka 2
NO - Norvegia 2
OM - Oman 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CV - Capo Verde 1
Totale 27.692
Città #
Santa Clara 2.411
Ashburn 1.506
Warsaw 1.330
Fairfield 1.310
Singapore 1.148
Hong Kong 692
Woodbridge 581
Dublin 530
Seattle 515
Seoul 504
Chandler 502
Cambridge 500
Houston 477
Wilmington 399
Hefei 342
Milan 334
Beijing 318
San Jose 297
Altamura 225
Jacksonville 221
Lawrence 216
Ann Arbor 200
Buffalo 192
Ho Chi Minh City 167
Los Angeles 164
Rome 155
Princeton 153
Lauterbourg 145
The Dalles 140
Florence 130
Hanoi 124
Moscow 109
Munich 104
New York 101
Boston 98
Mumbai 97
Boardman 88
Melbourne 85
Dallas 78
Paris 76
Kent 70
Medford 69
San Diego 63
Council Bluffs 61
Tokyo 60
Helsinki 56
Shanghai 55
Izmir 51
Turin 51
São Paulo 50
Bologna 46
Naples 45
Dearborn 43
Orem 42
Turku 39
Chicago 34
Montreal 33
London 30
Norwalk 30
Chennai 26
Dong Ket 26
Bern 25
Clifton 25
Genoa 25
Redondo Beach 23
Yubileyny 23
Abidjan 22
Bari 22
Denver 22
Guangzhou 22
Brooklyn 21
Jakarta 21
Toronto 21
Da Nang 20
Haiphong 20
Miano 20
Palermo 20
Phoenix 20
Abuja 19
Falls Church 19
Atlanta 18
Andover 16
Biên Hòa 16
Brasília 16
Catania 16
Shenzhen 16
Barcelona 15
Bengaluru 15
Johannesburg 15
Tianjin 15
Venice 15
Brussels 14
Frankfurt am Main 14
Hillsboro 14
Mexico City 14
Pescara 14
San Francisco 14
West Jordan 14
Brno 13
Quito 13
Totale 18.451
Nome #
The Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): normative values with gender, age and education corrections in the Italian population. 481
EPIDURAL ANALGESIA AND CESAREAN DELIVERY IN MULTIPLE SCLEROSIS POST PARTU RELAPSES: THE ITALIAN COHORT STUDY. 333
Improving the characterization of radiologically isolated syndrome suggestive of multiple sclerosis. 321
Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric study. 314
Increased CD8+ T cell responses to apoptotic T cell-associated antigens in multiple sclerosis. 309
Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study. 307
Improvement on the Coma Recovery Scale–Revised During the First Four Weeks of Hospital Stay Predicts Outcome at Discharge in Intensive Rehabilitation After Severe Brain Injury 285
Relevance of brain lesion location to cognition in relapsing multiple sclerosis 278
Computer-assisted rehabilitation of attention in patients with multiple sclerosis: results of a randomized, double-blind trial. 266
Impact of natalizumab on cognitive performances and fatigue in relapsing multiple sclerosis: a prospective, open-label, two years observational study. 264
The Rao's Brief Repeatable Battery version B: normative values with age, education and gender corrections in an Italian population. 257
A comparison of the brief international cognitive assessment for multiple sclerosis and the brief repeatable battery in multiple sclerosis patients 253
THE RAO'S BRIEF REPEATABLE BATTERY AND STROOP TEST: NORMATIVE VALUES WITH AGE, EDUCATION AND GENDER CORRECTIONS IN AN ITALIAN POPULATION. 245
Anxiety state affects information processing speed in patients with multiple sclerosis. 245
Appraisal of brain connectivity in radiologically isolated syndrome by modeling imaging measures. 228
Score on Coma Recovery Scale-Revised at admission predicts outcome at discharge in intensive rehabilitation after severe brain injury 228
Cognitive impairment in multiple sclerosis: An exploratory analysis of environmental and lifestyle risk factors 225
A short version of Rao's Brief Repeatable Battery as a screening tool for cognitive impairment in multiple sclerosis. 220
Association of MRI metrics and cognitive impairment in radiologically isolated syndromes. 217
Thrombotic Microangiopathy as a Life-Threatening Complication of Long-Term Interferon Beta Therapy for Multiple Sclerosis: Clinical Phenotype and Response to Treatment—A Literature Review 212
Prevalence of patient-reported dysphagia in multiple sclerosis patients: an Italian multicenter study (using the DYMUS questionnaire). 212
Prognostic role of intrathecal IgM synthesis in multiple sclerosis: Results from a clinical series 212
Cognitive reserve and cortical atrophy in multiple sclerosis: a longitudinal study. 211
Cognitive impairment and event-related potentials in paediatric multiple sclerosis: 2-year study. 211
Pronounced Structural and Functional Damage in Early Adult Pediatric-Onset Multiple Sclerosis with No or Minimal Clinical Disability 211
Cognitive impairment in early stages of multiple sclerosis. 211
Aging process, adherence to Mediterranean diet and nutritional status in a large cohort of nonagenarians: Effects on endothelial progenitor cells 210
Causes of diplopia in the emergency department: diagnostic accuracy of clinical assessment and of head computed tomography 208
BRAIN DAMAGE AS DETECTED BY MAGNETIZATION TRANSFER IMAGING IS LESS PRONOUNCED IN BENIGN THAN IN EARLY RELAPSING MULTIPLE SCLEROSIS. 204
Multiple Sclerosis Progression and Relapse Activity in Children 200
Aging with multiple sclerosis: prevalence and profile of cognitive impairment 197
Critical illness-polyneuromyopathy: functional impact after severe Acquired Brain Injuries 197
Immunohistochemistry analysis of bone marrow biopsies in multiple sclerosis patients undergoing autologous haematopoietic stem cells transplantation 196
Impact of cognitive impairment on coping strategies in multiple sclerosis. 194
Decannulation and improvement of responsiveness in patients with disorders of consciousness 194
Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis. 193
Withdrawal of fingolimod treatment for relapsing-remitting multiple sclerosis: report of six cases. 190
Disease-modifying drugs can reduce disability progression in relapsing multiple sclerosis 190
Cognitive rehabilitation in children and adolescents with multiple sclerosis. 190
Cognitive and psychosocial features in childhood and juvenile MS: two-year follow-up. 189
Brain metabolic changes suggestive of axonal damage in radiologically isolated syndrome. 188
Changes in neuropsychological test performance over the workday in multiple sclerosis. 183
ApolipoproteinE epsilon 4 allele is not associated with disease course and severity in multiple sclerosis. 182
Association of Neocortical Volume Changes with Cognitive Deterioration in Relapsing-Remitting Multiple Sclerosis 181
NEOCORTICAL VOLUME DECREASE IN RELAPSING-REMITTING MULTIPLE SCLEROSIS WITH MILD COGNITIVE IMPAIRMENT. 179
Age and disability drive cognitive impairment in multiple sclerosis across disease subtypes 179
Emotional and neutral verbal memory impairment in Multiple Sclerosis. 177
RESPONSE TO INTERFERON-BETA THERAPY IN RELAPSING-REMITTING MULTIPLE SCLEROSIS: A COMPARISON OF DIFFERENT CLINICAL CRITERIA. 174
Are there protective treatments for cognitive decline in MS? 174
Author response: Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks 174
EEG and Coma Recovery Scale-revised prediction of neurological outcome in Disorder of Consciousness patients 174
Cognitive and psychosocial features of childhood and juvenile MS. 173
Posterior brain damage and cognitive impairment in pediatric multiple sclerosis. 173
Cognitive impairment in multiple sclerosis. 173
BENIGN MULTIPLE SCLEROSIS: COGNITIVE, PSYCHOLOGICAL AND SOCIAL ASPECTS IN A CLINICAL COHORT. 172
No association between chronic cerebrospinal venous insufficiency and pediatric-onset multiple sclerosis. 171
Postpartum relapses increase the risk of disability progression in multiple sclerosis: the role of disease modifying drugs. 168
Cognitive changes in multiple sclerosis 167
Patients with paediatric-onset multiple sclerosis are at higher risk of cognitive impairment in adulthood: An Italian collaborative study 167
Experience with rituximab therapy in a real-life sample of multiple sclerosis patients 166
Prognostic value of post-acute EEG in severe disorders of consciousness, using American Clinical Neurophysiology Society terminology 166
Cerebrospinal fluid igm and oligoclonal igg bands in multiple sclerosis: A meta-analysis of prevalence and prognosis 166
New natural history of interferon-b treated relapsing multiple sclerosis 165
Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis 164
Breastfeeding is not related to postpartum relapses in multiple sclerosis. 164
Cognitive reserve is a determinant of social and occupational attainment in patients with pediatric and adult onset multiple sclerosis 163
Disease-Modifying Treatments and Time to Loss of Ambulatory Function in Patients with Primary Progressive Multiple Sclerosis 162
Absence of cerebrospinal fluid oligoclonal bands is associated with delayed disability progression in relapsing-remitting MS patients treated with interferon-beta 162
Psychosocial issue in children and adolescents with multiple sclerosis. 161
Impact of COVID-19 on pregnancy and fetal outcomes in women with multiple sclerosis 160
The contribution of cerebrospinal fluid oligoclonal band sto the early diagnosis of multiple sclerosis 160
Gray matter atrophy cannot be fully explained by white matter damage in patients with MS 160
Progression is independent of relapse activity in early multiple sclerosis: a real-life cohort study 160
Multiple sclerosis-related cognitive changes: a review of cross-sectional and longitudinal studies. 158
Subclinical MS. Follow-up of four cases 157
The Brain-Derived Neurotrophic Factor Val66Met Polymorphism Can Protect Against Cognitive Impairment in Multiple Sclerosis 156
Relevance of hypointense brain MRI lesions for long-term worsening of clinical disability in relapsing multiple sclerosis. 155
Coping strategies, cognitive impairment, psychological variables and their relationship with quality of life in multiple sclerosis. 154
Long-term Cognitive Outcomes and Socioprofessional Attainment in People With Multiple Sclerosis With Childhood Onset 153
Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks 152
Comparing Natural History of Early and Late Onset Pediatric Multiple Sclerosis 151
Pregnancy in multiple sclerosis women with relapses in the year before conception increases the risk of long-term disability worsening 149
Early prediction of unfavorable evolution after a first clinical episode suggestive of multiple sclerosis: the EUMUS score 148
Cognitive impairment predicts conversion to multiple sclerosis in clinically isolated syndromes. 148
Immunomodulatory therapies delay disease progression in multiple sclerosis. 148
Reliability, practice effects, and change indices for Rao's Brief Repeatable Battery. 148
Rebound after Fingolimod suspension in a pediatric-onset multiple sclerosis patient. 147
Fertility, pregnancy and childbirth in patients with multiple sclerosis: impact of disease-modifying drugs. 147
Maturational Trajectory of Processing Speed Performance in Pediatric Multiple Sclerosis 147
Identifying the Distinct Cognitive Phenotypes in Multiple Sclerosis 147
Sars-CoV2 infection in pregnant women with multiple sclerosis 146
Switching to second-line therapies in interferon- beta treated relapsing-remitting multiple sclerosis patients 146
CMV AND EBV REACTIVATION AFTER AUTOLOGOUS HAEMOPOIETIC STEM CELL TRANSPLANTATION WITH BEAM CONDITIONING REGIMEN FOR MULTIPLE SCLEROSIS AND LYMPHOMA: A RETROSPECTIVE SINGLE CENTER CASE-CONTROL STUDY 146
Cognitive impairment in pediatric multiple sclerosis. 144
A first step towards preventive medicine in multiple sclerosis 143
Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: Maternal risks 143
Interobserver agreement on Poser's and the new McDonald's diagnostic criteria for multiple sclerosis. 141
Safety and tolerability of cyclophosphamide 'pulses' in multiple sclerosis: a prospective study in a clinical cohort. 141
Impact of occupational complexity on cognitive decline in the oldest-old 141
Hypogammaglobulinemia is associated with reduced antibody response after anti-SARS-CoV-2 vaccination in MS patients treated with antiCD20 therapies 141
Totale 19.113
Categoria #
all - tutte 77.568
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.568


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.032 41 110 89 31 31 42 61 62 52 41 210 262
2022/20232.605 259 589 119 159 176 433 341 136 261 13 74 45
2023/20241.042 53 103 164 84 92 76 48 182 17 84 98 41
2024/20256.989 268 725 379 996 1.946 1.011 110 350 377 224 263 340
2025/20268.980 1.016 1.165 832 739 1.060 315 817 492 491 531 307 1.215
2026/2027370 370 0 0 0 0 0 0 0 0 0 0 0
Totale 27.928